Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lower Urinary Tract Symptoms 1 Hypogonadism 1 Gynecomastia 1 Erectile Dysfunction 1

Interventions

Alendronate 2 testosterone undecanoate 1 testosterone 17 beta-cypionate 1 Triptorelin Pamoate 1 Testosterone Propionate 1 Testosterone 1 Tamoxifen 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Orchiectomy 1 Methyltestosterone 1 Mental Status and Dementia Tests 1 Castor Oil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hypogonadism × Tamoxifen × Genitourinary × Clear all

NCT07535905 2026-04-17

REVIVE

University Health Network, Toronto

Phase 2 Not yet recruiting

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡